FOPE urges pause on NPPA notice, citing potential losses for pharma industry

FOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the price expeditiously and as per the NPPA's defined timelines for various provisions under DPCO including disposal of Form-1 application.
Read The Rest at :